Cancer Panels
Cancer panels use next generation sequencing (NGS) technology to target specific genes or mutations that have established relevancy to a particular cancer phenotype.
Single-Cell ATAC-Seq (scATAC-Seq)
Single-cell ATAC-Seq (scATAC-Seq) utilizes microfluidics and molecular barcoding to investigate chromatin accessibility in hundreds to thousands of individual nuclei from a single sample.
ChIP-Seq
ChIP-Seq (chromatin immunoprecipitation sequencing) combines the highly effective chromatin immunoprecipitation (ChIP) methodology and next generation sequencing (NGS) to analyze protein-DNA interactions.
ATAC-Seq
ATAC-Seq is a technique used to analyze the functional state of chromatin at the genome-wide level. The assay for transposase-accessible chromatin sequencing identifies regions of open chromatin and efficiently labels them for high-throughput sequencing.
Methylation Sequencing
Methylation sequencing is the process in which DNA methylation is quantified using sodium bisulfite and subsequent nucleotide base conversion. To uncover the methylome, GENEWIZ uses wet and dry lab solutions, including Methyl-Seq, for global whole genome and targeted 5-methylcytosine (5mC) detection.
OncoGxOne
GENEWIZ OncoGxOne™ Discovery cancer panels provide comprehensive genomic analysis for cancer research, biomarker discovery, and patient stratification.
Custom-Targeted-Sequencing
GENEWIZ TargetGxOne™ custom gene panels provide targeted resequencing of any gene of interest via next generation sequencing (NGS).
Custom Short-Read Amplicon Sequencing
GENEWIZ routinely sequences pre-made amplicons on Illumina platforms to answer a myriad of biological questions.
Long-Read Amplicon Sequencing
GENEWIZ offers ultra-deep, contiguous amplicon sequencing for sequences up to 10,000 bp.
Immuno-Profiling
Immune Profiling couples ultra-deep sequencing of V(D)J regions and customized bioinformatics to provide comprehensive characterization of the entire B-cell receptor (BCR) and T-cell receptor (TCR) repertoire.